Jama Intern News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jama Intern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jama Intern Today - Breaking & Trending Today

SGLT2i Use Linked to Lower Risk of Nephrolithiasis in Patients With Type 2 Diabetes

Published: January 29, 2024

Compared to glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, Use of sodium-glucose cotransporter 2 inhibitors was linked to a decreased risk of nephrolithiasis in patients with type 2 diabetes.

Source: hcplive.com

Related Topics:

Julie PaikUs Centers For DiseaseCenters For DiseaseHarvard Medical SchoolWomen Hospital Harvard Medical School Julie PaikDisease ControlClinformatics Data Mart DatabaseMedicare Fee For Service PartsGlucose CotransporterNephrolithiasis RiskPatients With TypeJama InternChronic KidneyKidney StoneType 2 DiabetesSodium Glucose Cotransporter 2 InhibitorGlucagon Like Peptide 1 Receptor AgonistGlp 1raDipeptidyl Peptidase 4 Inhibitor